Introduction There is evidence that low-dose naltrexone (LDN; <5.0 mg/day) reduces pain and improves the quality of life of people with fibromyalgia syndrome (FMS). However, no randomised controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback